Boston Scientific Finished goods increased by 1.1% to $1.83B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $1.69B to $1.83B. Over 4 years (FY 2020 to FY 2024), Finished goods shows an upward trend with a 19.1% CAGR.
current_assets_inventory_finished_goods_net_of_reserves| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $933.00M | $1.04B | $1.03B | $1.10B | $1.08B | $1.11B | $1.17B | $1.22B | $1.37B | $1.47B | $1.54B | $1.56B | $1.56B | $1.69B | $1.80B | $1.81B | $1.81B | $1.83B |
| QoQ Change | — | +11.4% | -1.0% | +6.4% | -1.2% | +2.3% | +5.8% | +4.4% | +12.2% | +6.9% | +4.8% | +1.2% | +0.2% | +8.3% | +6.6% | +0.4% | +0.2% | +1.1% |
| YoY Change | — | — | — | — | +16.0% | +6.5% | +13.8% | +11.7% | +26.8% | +32.4% | +31.3% | +27.1% | +13.6% | +15.1% | +17.0% | +16.1% | +16.0% | +8.3% |